Tag: Crizotinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Crizotinib

Cheap shots EQRX wants to make high-end medicines less costly

Added to Collection on: 2020-01-16 00:30:00

Tags for this article:

Life Sciences
Health sciences
Pharmaceutical industry
Health care
Drug pricing
Pharmacy
Biotechnology
Pharmaceuticals policy
Biosimilar
Medication costs
Crizotinib
Medication

Click the tags to see associated articles and topics

View Article Details
Pfizer's XALKORI® (crizotinib) Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma ...

Added to Collection on: 2021-01-14 21:22:30

Tags for this article:

Chemical compounds
Tyrosine kinase receptors
Piperidines
Organic compounds
Lung cancer
Chloroarenes
Crizotinib
Pyrazoles
Anaplastic lymphoma kinase
Anaplastic large-cell lymphoma
ROS1
Non-small-cell lung carcinoma
United States
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Pfizer's XALKORI Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children ...

Added to Collection on: 2021-01-14 21:22:30

Tags for this article:

Chemical compounds
Tyrosine kinase receptors
Piperidines
Organic compounds
Lung cancer
Lymphoma
Chloroarenes
Crizotinib
Anaplastic lymphoma kinase
Anaplastic large-cell lymphoma
ROS1
Non-small-cell lung carcinoma
Pfizer Inc.
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
FDA Approves Pfizer Med for Rare Form of Pediatric Non-Hodgkin Lymphoma

Added to Collection on: 2021-01-15 16:07:30

Tags for this article:

Chemical compounds
Piperidines
Organic compounds
Protein kinase inhibitors
Tyrosine kinase receptors
Breakthrough therapy
Lung cancer
Anaplastic lymphoma kinase
Crizotinib
Anaplastic large-cell lymphoma
ROS1
Ceritinib

Click the tags to see associated articles and topics

View Article Details
Pfizer's Lorbrena breaks into front-line ALK lung cancer, jostling with Novartis, Roche and Takeda

Added to Collection on: 2021-03-04 15:45:00

Tags for this article:

Chemical compounds
Piperidines
Organic compounds
Chemistry
Protein kinase inhibitors
Breakthrough therapy
Orphan drugs
Lung cancer
Ceritinib
Crizotinib
ALK inhibitor
Anaplastic lymphoma kinase
Pfizer
XALKORI
Lorbrena
PFIZER'S

Click the tags to see associated articles and topics

View Article Details
Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer ...

Added to Collection on: 2021-03-09 06:00:00

Tags for this article:

Chemical compounds
Organic compounds
Piperidines
Chemistry
Lung cancer
Breakthrough therapy
Protein kinase inhibitors
Tyrosine kinase receptors
Anaplastic lymphoma kinase
Ceritinib
Crizotinib
Alectinib
Roche Group

Click the tags to see associated articles and topics

View Article Details
Innovent's ROS1 TKI closer to winning the Chinese NSCLC market

Added to Collection on: 2024-03-08 19:50:36

Tags for this article:

Tyrosine kinase receptors
Orphan drugs
Tyrosine kinase inhibitors
ROS1
CYP3A4 inhibitors
Lung cancer
Entrectinib
Anaplastic lymphoma kinase
Crizotinib
Non-small-cell lung cancer
Repotrectinib
Amgen
China

Click the tags to see associated articles and topics

View Article Details
Roche wins FDA OK for Alecensa in early lung cancer - Yahoo Finance

Added to Collection on: 2024-04-19 17:50:43

Tags for this article:

Lung cancer
Tyrosine kinase receptors
Fluoroarenes
ROS1
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Brain metastasis
Crizotinib
Alectinib
Cancer
ALK positive lung cancer
Treatment of lung cancer

Click the tags to see associated articles and topics

View Article Details
Taletrectinib Provides “Prolonged Disease Control” in ROS1+ NSCLC

Added to Collection on: 2025-05-02 19:19:35

Tags for this article:

Tyrosine kinase receptors
ROS1
Tyrosine kinase inhibitors
Lung cancer
CYP3A4 inhibitors
Crizotinib
Non-small-cell lung cancer
Progression-free survival
Entrectinib
Brain metastasis
Clinical endpoint

Click the tags to see associated articles and topics

View Article Details
Roche data at ESMO 2025 showcase advances in science and cancer care across multiple ...

Added to Collection on: 2025-10-13 07:00:49

Tags for this article:

Orphan drugs
Antineoplastic drugs
Selective estrogen receptor degraders
Clusters of differentiation
Tyrosine kinase receptors
Alectinib
Atezolizumab
Giredestrant
Genentech
Non-small-cell lung cancer
Anaplastic lymphoma kinase
HER2
Germany
Crizotinib
Berlin
Roche Group

Click the tags to see associated articles and topics

View Article Details
Book a Demo